ASCEND BY NTHRYS
Research Abroad Products

Cancer Systems Biology Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 200 project topics
AI-Powered Protein-Protein Interaction Mapping Platform
A SaaS platform that uses machine learning to predict and visualize protein-protein interactions (PPIs) in cancer networks, enabling identification of novel drug targets. Delivers recurring revenue through subscription tiers while reducing target discovery timelines from months to weeks for pharmaceutical clients.
Cancer Network Model Drug Target Discovery Click to view more details →
Cancer Signaling Pathway Dependency Analysis Software Suite
Enterprise software that integrates multi-omics data to identify critical pathway dependencies and synthetic lethal interactions in tumor networks. Generates revenue through per-analysis licensing and partnerships with biotech companies conducting drug candidate validation.
Cancer Network Model Drug Target Discovery Click to view more details →
Real-Time Tumor Heterogeneity Network Visualization Tool
A cloud-based interactive platform that maps single-cell and spatial transcriptomics data into dynamic tumor ecosystem networks for target prioritization. Monetizes through data processing fees, white-label solutions for CROs, and premium analytics features.
Cancer Network Model Drug Target Discovery Click to view more details →
Predictive Biomarker Network Models for Precision Oncology
A computational service that builds patient-specific cancer network models to predict drug response and identify personalized therapeutic targets. Generates B2B revenue through integration with companion diagnostic services and precision medicine platforms.
Cancer Network Model Drug Target Discovery Click to view more details →
Immunotherapy Resistance Network Prediction and Target Engine
SaaS platform employing network pharmacology to decode immune evasion pathways and predict resistance mechanisms in checkpoint inhibitor treatments. Delivers commercial value through licensing to immunotherapy developers and enabling second-line therapy development.
Cancer Network Model Drug Target Discovery Click to view more details →
Multi-Omics Cancer Network Integration and Hub Identification
An automated pipeline tool that integrates genomics, proteomics, and metabolomics datasets to identify master regulator hubs as drug targets. Provides revenue through enterprise licenses, data analysis services, and integration partnerships with sequencing platforms.
Cancer Network Model Drug Target Discovery Click to view more details →
Patient-Derived Network Models for Preclinical Drug Screening
A commercial service that constructs patient-specific tumor network models for in vitro and in silico drug screening and target validation. Monetizes through per-patient model fees, partnership revenue with pharma companies, and high-throughput screening contracts.
Cancer Network Model Drug Target Discovery Click to view more details →
Druggable Network Node Discovery Using Graph Machine Learning
An AI platform that applies graph neural networks to cancer interaction networks to score and rank undrugged targets by tractability and therapeutic potential. Captures value through software licensing, target nomination services, and performance-based fees from successful clinical candidates.
Cancer Network Model Drug Target Discovery Click to view more details →
Cancer Metabolism Network Rewiring and Intervention Platform
A specialized platform modeling tumor metabolic networks to identify non-oncogene dependencies and metabolic vulnerabilities as drug targets. Generates revenue through licensing to metabolic drug developers and collaboration fees with pharmaceutical companies.
Cancer Network Model Drug Target Discovery Click to view more details →
Tumor Microenvironment Network Modeling for Combination Therapy
Enterprise software that models interactions between cancer cells, immune cells, and stromal components to predict synergistic combination drug targets. Delivers commercial value through licensing fees, partnership programs with combination therapy developers, and data licensing.
Cancer Network Model Drug Target Discovery Click to view more details →
Integrated Multi-Omics Data Integration and Analytics Platform
A cloud-based SaaS platform that ingests and harmonizes genomics, proteomics, transcriptomics, and metabolomics data from patient cohorts into unified analytical workflows. The platform enables pharmaceutical companies and biotech firms to accelerate drug discovery by reducing data integration time by 60% and identifying novel therapeutic targets 3-4 months faster than traditional methods.
Multi-Omics Cancer Systems Biology Platforms Click to view more details →
Real-Time Cancer Mutation Tracking and Clonal Evolution Engine
A commercial software tool that monitors tumor heterogeneity and clonal dynamics through continuous multi-omics surveillance and AI-driven phylogenetic reconstruction. This service supports oncology clinics and research hospitals with actionable resistance predictions, enabling treatment optimization decisions that increase median progression-free survival and improve patient stratification for adaptive clinical trials.
Multi-Omics Cancer Systems Biology Platforms Click to view more details →